🔎 Trials Near Me

Home › Cancer (all types) › Illinois › Chicago

Cancer (all types) clinical trials in Chicago, IL

51 studies for Cancer (all types) are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

RecruitingPhase 1
  • University of Chicago Medical Center /ID# 278863, Chicago
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07409246

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

RecruitingObservational study
  • Northwestern University, Chicago
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05874921

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

RecruitingPhase 3
  • Investigative Site, Chicago
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06881992

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

RecruitingPhase 3
  • Northwestern Memorial Hospital, Chicago
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06901531

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

RecruitingPhase 3
  • University of Chicago Medical Center /ID# 280149, Chicago
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

RecruitingPhase 2
  • Cancer Treatment Centers of America-Chicago, Chicago
Ages 12 and older · All sexes · Updated Sep 22, 2026 · NCT02693535

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

RecruitingPhase 2/3
  • Northwestern Memorial Hospital, Chicago
  • University Of Chicago Medical Center, Chicago
All ages · All sexes · Updated Sep 18, 2026 · NCT03435796

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

RecruitingPhase 2
  • Rush University Medical Center, Chicago
  • University of Chicago Medical Center, Chicago
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034

Evaluating the Communication Between Patients and Providers in Cancer Clinics

Recruiting
  • Northwestern Memorial Hospital, Chicago
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06985953

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

Recruiting
  • Advocate Illinois Masonic Medical Center, Chicago
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT06756607

A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

RecruitingPhase 1
  • Northwestern University ( Site 0101), Chicago
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07030712

A Phase 1/1b Study of IAM1363 in HER2 Cancers

RecruitingPhase 1
  • University of Chicago, Chicago
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06253871

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RecruitingPhase 3
  • University of Illinois at Chicago, Chicago
  • University of Chicago Hospital, Chicago
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

RecruitingObservational study
  • Northwestern University Feinberg School of Medicine, Chicago
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06163534

Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)

RecruitingObservational study
  • Ann &Robert H Lurie Children's Hospital, Chicago
Up to age 30 · Women · Updated Sep 3, 2026 · NCT05309746

Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)

RecruitingObservational study
  • Ann & Robert H Lurie Childrens Hospital, Chicago
Up to age 11 · Women · Updated Sep 3, 2026 · NCT05299710

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

RecruitingPhase 3
  • Northwestern University, Chicago
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06072612

Project: Every Child for Younger Patients With Cancer

RecruitingObservational study
  • Lurie Children's Hospital-Chicago, Chicago
  • Northwestern University, Chicago
  • University of Illinois, Chicago
  • and 1 more
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244

Abatacept in Immune Checkpoint Inhibitor Myocarditis

RecruitingPhase 3
  • University of Chicago, Chicago
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05335928

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

RecruitingPhase 1/2
  • Site 05, Chicago
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07276373

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

RecruitingPhase 1/2
  • University of Chicago Medical Center, Chicago
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04104776

Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer

RecruitingObservational studyHealthy volunteers welcome
  • Tempus AI, Chicago
All ages · All sexes · Updated Aug 10, 2026 · NCT07756034

International Rare Brain Tumor Registry

RecruitingObservational study
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Up to age 45 · All sexes · Updated Aug 7, 2026 · NCT05697874

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

RecruitingPhase 2
  • Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Ages 1 to 39 · All sexes · Updated Aug 7, 2026 · NCT05999994

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

RecruitingPhase 3
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
  • and 1 more
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT06580314

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

RecruitingPhase 2
  • Lurie Children's Hospital, Chicago
Ages 1 to 26 · All sexes · Updated Aug 4, 2026 · NCT07680439

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • The University of Chicago Medicine, Chicago
Ages 12 and older · All sexes · Updated Jul 14, 2026 · NCT05533697

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

Recruiting
  • Northwestern University, Chicago
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT07556380

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

Recruiting
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
Ages 14 and older · All sexes · Updated Jun 30, 2026 · NCT03932903

Molecular Genetics Studies of Cancer Patients and Their Relatives

RecruitingObservational studyHealthy volunteers welcome
  • John H Stroger Jr Hospital of Cook County, Chicago
  • Rush University Medical Center, Chicago
All ages · All sexes · Updated Jun 29, 2026 · NCT04185935

Advancing Cancer Control Engaged Research Through Transformative Solutions (ACCERT) Social Determinants of Health (SDoH) Navigation Program

RecruitingHealthy volunteers welcome
  • Northwestern University, Chicago
Ages 18 and older · All sexes · Updated Jun 25, 2026 · NCT07669753

Childhood Cancer Survivor Study

RecruitingObservational studyHealthy volunteers welcome
  • Ana & Robert H. Lurie Children's Hospital of Chicago, Chicago
  • University of Chicago, Chicago
All ages · All sexes · Updated Jun 17, 2026 · NCT01120353

Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy

RecruitingPhase 1/2
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Ages 18 and older · All sexes · Updated Jun 16, 2026 · NCT07354100

CT-95 in Advanced Cancers Associated With Mesothelin Expression

RecruitingPhase 1
  • Context Investigational Site, Chicago
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06756035

Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells

RecruitingObservational study
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
All ages · All sexes · Updated Jun 3, 2026 · NCT05120518

My Wellbeing Guide: A Novel Tool for Managing Stress and Improving Quality of Life

Recruiting
  • Northwestern University, Chicago
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05369429

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

RecruitingPhase 1/2
  • University of Chicago, Chicago
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

RecruitingPhase 1/2
  • University of Chicago Medical Center, Chicago
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT03686124

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

RecruitingPhase 2
  • University of Chicago, Chicago
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT01042379

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

RecruitingPhase 1/2
  • Northwestern Memorial Hospital, Chicago
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT03328078

Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

Recruiting
  • University of Chicago Medicine, Chicago
Ages 18 and older · All sexes · Updated Mar 4, 2026 · NCT05166694

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

RecruitingPhase 1/2
  • University of Chicago Medical Center, Chicago
Ages 18 and older · All sexes · Updated Mar 2, 2026 · NCT06014658

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Chicago
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

RecruitingPhase 1
  • Northwestern University, Chicago
  • University of Illinois, Chicago
Ages 18 and older · All sexes · Updated Sep 25, 2025 · NCT05808634

A Study of NX-1607 in Adults With Advanced Malignancies

RecruitingPhase 1
  • University of Chicago, Chicago
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT05107674

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Recruiting
  • Advocate Illinois Masonic Medical Center, Chicago
Ages 18 and older · All sexes · Updated Nov 27, 2024 · NCT03860883

DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies

RecruitingObservational study
  • Thoracic Surgery, Canning Thoracic Institute (Northwestern Memorial Hospital), Chicago
Ages 18 to 75 · All sexes · Updated Nov 14, 2024 · NCT05671887

About Cancer (all types)

If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.

More about Cancer (all types) on MedlinePlus

Cancer (all types) trials in other cities

Other studies in Chicago

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.